assembly Bill A4141

2023-2024 Legislative Session

Caps cost sharing for insulin

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (1)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Feb 10, 2023 referred to insurance

Co-Sponsors

view additional co-sponsors

A4141 (ACTIVE) - Details

See Senate Version of this Bill:
S504
Current Committee:
Assembly Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in Other Legislative Sessions:
2019-2020: A10821, S8255
2021-2022: A2383, S1413

A4141 (ACTIVE) - Summary

Lowers the cost sharing cap for insulin from one hundred dollars per thirty-day supply to thirty dollars per calendar month.

A4141 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   4141
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 10, 2023
                                ___________
 
 Introduced  by M. of A. FORREST -- read once and referred to the Commit-
   tee on Insurance
 
 AN ACT to amend the insurance law, in relation to capping  cost  sharing
   for insulin
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Subparagraph (B) of paragraph 15-a  of  subsection  (i)  of
 section  3216  of the insurance law, as amended by section 1 of part DDD
 of chapter 56 of the laws of 2020, is amended to read as follows:
   (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided however, the total amount that [a covered person] AN INSURED is
 required  to  pay  out  of pocket for covered prescription insulin drugs
 shall be capped IN AGGREGATE, INCLUDING SITUATIONS WHERE THE INSURED  IS
 PRESCRIBED  MORE  THAN ONE INSULIN DRUG, at an amount not to exceed [one
 hundred] THIRTY dollars per [thirty-day supply] CALENDAR MONTH,  regard-
 less  of  the  amount  or  type  of insulin needed to fill such [covered
 person's] INSURED'S prescription and regardless of the insured's deduct-
 ible, copayment, coinsurance or any other cost sharing requirement.
   § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
 of the insurance law, as amended by section 2 of part DDD of chapter  56
 of the laws of 2020, is amended to read as follows:
   (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with  those  established  for  other  benefits  within  a  given policy;
 provided however, the total amount that [a covered person] AN INSURED is
 required to pay out of pocket for  covered  prescription  insulin  drugs
 shall  be capped IN AGGREGATE, INCLUDING SITUATIONS WHERE THE INSURED IS
 PRESCRIBED MORE THAN ONE INSULIN DRUG, at an amount not to  exceed  [one
 hundred]  THIRTY dollars per [thirty-day supply] CALENDAR MONTH, regard-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD02649-02-3